Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-93.35	42.10	632.69
Graham Fair Price	315.67	4.27	1.03
PEG	-99.74	< 0.005	-3.16
Price/Book	-16.83	1.86	2.23
Price/Cash Flow	-88.38	-22.41	192.89
Prices/Earnings	-94.83	13.14	254.06
Price/Sales	-52.71	7.14	15.11
Price/FCF	-88.38	-22.41	192.89
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.39	0.61	0.55
Operating Margin	321.03	0.14	-0.03
ROA	1450.40	0.03	< 0.005
ROE	< 0.005	0.04	1507.99
ROIC	< 0.005	0.03	38155.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	-0.21	63.01
Dividends QOQ	-1.00	-1.00	-0.04
EBIT QOQ	-1.39	8.68	524.49
EPS QOQ	-0.80	15.83	1871.28
FCF QOQ	1.48	-8.42	469.05
Revenue QOQ	0.06	0.82	1307.45
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	330.06	180.59	-45.29
Days Sales Outstanding (DSO)	157.90	148.70	-5.83
Inventory Turnover	0.27	0.50	82.77
Debt/Capitalization	0.04	0.04	-10.69
Quick Ratio	1.50	1.56	4.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.62	4.79	3.66
Cash	1.06	0.77	-27.08
Capex	-0.03	-0.04	-74.74
Free Cash Flow	0.05	-0.40	642.22
Revenue	0.68	1.24	82.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.26	2.17	-4.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-36.98	-0.71	98.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating